Johnson & Johnson
OpenCalais Metadata: Ticker
Τον Φεβρουάριο αναμένεται η κατάθεση αίτησης της Johnson & Johnson για έγκριση του εμβολίου στην ΕΕ
US firm Johnson & Johnson is likely to apply for EU approval for its Covid-19 vaccine candidate in February, a top lawmaker said on Wednesday.
Clinical data of the vaccine, which Johnson & Johnson is developing through its subsidiary Janssen, have been assessed by the European Medicines Agency (EMA) since Dec. 1 under a rolling review to speed up possible approval.
The first 10,000 vaccines developed by Pfizer/Biontech will arrive on December 26 in Bulgaria.
On the next day the immunization will begin and the first vaccinated will be medics working on the front line in the fight against COVID 19. This became clear at the briefing of the National Operations Headquarters.
A Greek court has convicted 13 people in connection with alleged corruption during state hospital purchases from DePuy, a subsidiary of US healthcare giant Johnson & Johnson.
The Athens criminal court on Tuesday acquitted another seven people over the same case, in which Greek hospital doctors allegedly took bribes to prescribe DePuy orthopedic products.
US pharmaceutical giant Johnson & Johnson was Thursday ordered to pay out $4.69 billion in damages in a lawsuit representing 22 women and their families who alleged a talc sold by the company contained asbestos and caused them to suffer cancer.